AI eye on bladder cancer: could a smart navigation system help surgeons remove tumors more completely?

NCT ID NCT07727343

Not yet recruiting Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether an artificial intelligence system can help surgeons better see and remove bladder tumors during a standard procedure called TURBT. The AI analyzes the live video from the surgical camera and highlights suspicious areas and recommended cutting edges on the surgeon's screen. About 170 people with non-muscle invasive bladder cancer will be randomly assigned to receive either standard surgery or surgery with this AI guidance. The main question is whether the AI-assisted approach can reduce the chance of the cancer coming back after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an AI navigation planning system that overlays tumor boundaries on the surgical video feed during bladder tumor removal
What this could lead to: If it works, this AI tool could help surgeons remove bladder tumors more completely, potentially lowering the risk of cancer returning after surgery.
What could go wrong: This is a single-center trial with 170 people, so results may not apply broadly. The AI system's guidance might not improve outcomes over standard surgery, and technical issues could arise during use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

More trials for these conditions

Other studies related to the condition(s) this trial covers.